ARKRAY INDUSTRY, INC.
TaiwanPhilippines4 products registeredJan 06, 2016 – Jan 11, 2022
VerifiedTFDA · Taiwan Food and Drug Administration registry
4
Total products
3
Product types
3
Active products
Jan 2022
Latest registration
Company details
- Address
- LOT 22 PHASE 1A, FIRST PHILIPPINE INDUSTRIAL PARK, BRGY. STA. ANASTACIA, STO. TOMAS, BATANGAS 4234, PHILIPPINES
Regulatory footprint
Search ARKRAY INDUSTRY, INC. across other regulatory registries
Recent registrations
Latest 5 products registered by this manufacturer
Most popular products
Products with most registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
Recent registered products
Most recent products (showing top 20)
"AGCO" Biochemistry Analyzer (Unsterilized)
Registered: Jan 11, 2022 • Expires: Oct 31, 2025
- Risk Class
- Class 1
- AR
- SYNGEN BIOTECH CO., LTD.
"ARKRA" urinalysis tester (unsterilized)
Registered: Oct 01, 2021 • Expires: Oct 31, 2026
- Risk Class
- Class 1
- AR
- SYNGEN BIOTECH CO., LTD.
"Arkray" Multi-Lancet Device 2 (Non-sterile)
Registered: Apr 06, 2016 • Expires: Apr 06, 2021
- Risk Class
- Class 1
- Type
- MD
- AR
- SYNGEN BIOTECH CO., LTD.
"ARKRA" urinalysis tester (unsterilized)
Registered: Jan 06, 2016 • Expires: Jan 06, 2026
Cancelled
- Risk Class
- Class 1
- AR
- SYNGEN BIOTECH CO., LTD.
About this profile
Explore comprehensive manufacturer profile for ARKRAY INDUSTRY, INC. based in Philippines through Pure Global AI's free Taiwan medical device database. This manufacturer has 4 products registered in Taiwan across 3 unique product categories. Their regulatory history spans from Jan 06, 2016 to Jan 11, 2022.
This page provides detailed insights including 4 recent product registrations, 3 most popular products with "ARKRA" urinalysis tester (unsterilized) having 2 registrations, and 1 authorized representatives including SYNGEN BIOTECH CO., LTD.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.